Pharmafile Logo
Pharmafocus logo
Advanced Search
Pfizer picture

Pfizer recalls oral contraceptive for packaging errors

February 2, 2012
Manufacturing and Production Akrimax, Bedford, Cephalon, Lo/Ovral-28, Pfizer, Teva

Pfizer has been forced to recall a large volume of oral contraceptive packs distributed in the US market because a …

News
Zytiga image

Zytiga cost too high, says NICE

February 2, 2012
Sales and Marketing NICE, Zytiga

NICE is not recommending Janssen’s prostate cancer pill Zytiga because of its high cost. Zytiga (abiraterone) is not recommended, in …

News

RSA announces promotions

February 2, 2012
Medical Communications, Sales and Marketing rsa

Life sciences executive search and interim management specialist firm RSA, has announced its latest promotions.John Callagher (pictured) has been promoted …

Appointment

Sigma-Aldrich acquires testing company BioReliance

February 1, 2012
Research and Development Sigma-Aldrich

Sigma-Aldrich has acquired clinical testing company BioReliance for $350 million. Purchased from Avista Capital Partners, BioReliance provides services that include …

News

Pfizer weathers patent expiry storm

February 1, 2012

Pfizer has managed to keep its head above water in its full year results, but faces a tough 2012 without …

News

Kalydeco to be landmark in cystic fibrosis treatment

February 1, 2012
Vertex, cystic fibrosis, telaprevir

Vertex’s first-in-class treatment for cystic fibrosis Kalydeco has been approved by the FDA. The approval is a landmark in the …

News

NHS reforms criticised by healthcare journals

January 31, 2012
Sales and Marketing BMJ, GPs, Lansley, NHS reforms, nursing times

A trio of leading healthcare journals has come out against the government’s NHS reforms. The British Medical Journal is leading …

News

Catalent expands controlled release drug development and supply capabilities at its Schorndorf, Germany Facility

January 31, 2012
Manufacturing and Production

Somerset, NJ –January 25, 2012 — Catalent Pharma Solutions continues to expand its drug development and delivery capabilities to help …

News
Press release

Catalent acquires current minority interest in R.P. Scherer, Eberbach, Germany

January 31, 2012
Manufacturing and Production

SOMERSET, NJ, January 30, 2012 – Catalent Pharma Solutions, a leading global drug delivery technology company, today announced the signing …

News
Press release
Ranbaxy picture

Ranbaxy taken to task by FDA over manufacturing woes

January 31, 2012
Manufacturing and Production FDA, Ranbaxy, manufacturing, woes

Indian pharma company Ranbaxy will be banned from manufacturing drugs at certain plants for the US market until it corrects …

News

GMP issues affect Mircera, Xenical production at Roche plant

January 31, 2012
Manufacturing and Production GMP, Mircera, Roche, Tamiflu, Xenical

Supply of two Roche products has been disrupted after an active pharmaceutical ingredient (API) production facility in the US was …

News

Abbott slashes 700 jobs

January 31, 2012
Manufacturing and Production, Sales and Marketing Abbott, FDA, manufacturing

Abbott Laboratories has said it will cut 700 jobs across its US and Puerto Rican operations, including hundreds of manufacturing …

News

Pharma manufacturing news in brief

January 31, 2012
Manufacturing and Production Aptar Pharma, Granules-Omnichem, Lpath, Pii, Shemberg

Facility updates from Aptar Pharma, Granules-Omnichem and Pii, plus a fill/finish problem for Lpath and seaweed-based pharma capsules. Aptar Pharma …

News

Dietmar Leitner joins Napp Pharmaceuticals as its new managing director

January 31, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Dietmar Leitner, Napp Pharmaceuticals

Dietmar Leitner has been appointed managing director of Napp Pharmaceuticals, part of the Napp Pharmaceutical Group.   Dietmar has worked …

Appointment
Roche picture

Roche’s Erivedge gains FDA approval

January 31, 2012
Sales and Marketing Erivedge, FDA, Roche

The FDA has approved Roche’s Erivedge to treat patients with a common form of skin cancer. Erivedge (vismodegib) is now …

News

Misinformation charges against Servier dropped

January 30, 2012
Sales and Marketing European Commission, Servier, anti-competitive behaviour

The European Commission has dropped a case against Servier in which the French manufacturer was accused of providing misleading information.The …

News

Pfizer in talks on Sandwich site sale

January 30, 2012
Research and Development Pfizer, Sandwich

Pfizer has begun talks with a real estate investor to sell its R&D centre in Sandwich. The site was Pfizer’s …

News

PM Society celebrates new-look advertising awards

January 30, 2012
Medical Communications, Sales and Marketing Creative Lynx, Daaichi Sankyo, PM Society Awards, Torre Lazur McCann

The PM Society has held its annual healthcare advertising awards, which this year saw some significant changes to award categories. …

News

FDA approves Pfizer cancer drug Inlyta

January 30, 2012
Sales and Marketing Nexavar, Pfizer, Sutent, rcc, renal cell carcinoma

Pfizer’s kidney cancer drug Inlyta has gained US approval for second line treatment for the disease. Inlyta (axitinib) is now …

News

Government bites back against NHS reform naysayers

January 27, 2012
Sales and Marketing BMJ, Lansley, NHS, reforms

The UK government has come out against healthcare groups that are opposing its plans to radically reform the NHS.  Speaking …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026